On Invalid Date, Orthofix Medical (NASDAQ: OFIX) reported Q4 2023 earnings per share (EPS) of -$0.59, up 68.57% year over year. Total Orthofix Medical earnings for the quarter were -$22.17 million. In the same quarter last year, Orthofix Medical's earnings per share (EPS) was -$0.35.
As of Q2 2024, Orthofix Medical's earnings has grown year over year. Orthofix Medical's earnings in the past year totalled -$151.40 million.
What is OFIX's earnings date?
Orthofix Medical's earnings date is Invalid Date. Add OFIX to your watchlist to be reminded of OFIX's next earnings announcement.
What was OFIX's revenue last quarter?
On Invalid Date, Orthofix Medical (NASDAQ: OFIX) reported Q4 2023 revenue of $200.42 million up 63.97% year over year. In the same quarter last year, Orthofix Medical's revenue was $122.23 million.
What was OFIX's revenue growth in the past year?
As of Q2 2024, Orthofix Medical's revenue has grown 62.06% year over year. This is 52.67 percentage points higher than the US Medical Devices industry revenue growth rate of 9.39%. Orthofix Medical's revenue in the past year totalled $746.64 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.